M. Melhem

Improved growth factor directed vascularization into fibrin constructs through inclusion of additional extracellular molecules.

A. Waggoner, P. Campbell, J. Smith, 2007, Microvascular research.

Development of a Local Perivascular Paclitaxel Delivery System for Hemodialysis Vascular Access Dysfunction: Polymer Preparation and in vitroActivity

S. Heffelfinger, G. Kasting, P. Desai, 2006, Blood Purification.

Vascular access in hemodialysis: issues, management, and emerging concepts.

Prabir Roy-Chaudhury, S. Heffelfinger, P. Desai, 2005, Cardiology clinics.

Solutions for Hemodialysis Vascular access Dysfunction: Thinking out of the Box!!

B. Kelly, T. Husted, M. Melhem, 2005, The journal of vascular access.

Novel Therapies for Hemodialysis Vascular Access Dysfunction: Fact or Fiction!

S. Heffelfinger, P. Desai, B. Kelly, 2004, Blood Purification.

Novel peri-vascular drug delivery for the treatment of neointimal hyperplasia associated with Ptfe dialysis graft failure.

M. Melhem, 2004 .

Perivascular paclitaxel wraps block arteriovenous graft stenosis in a pig model.

S. Heffelfinger, G. Kasting, P. Desai, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Hemodialysis Vascular Access Dysfunction: From Pathophysiology to Novel Therapies

A. Narayana, S. Heffelfinger, P. Desai, 2003, Blood Purification.

In vitro Paclitaxel and Radiation Effects on the Cell Types Responsible for Vascular Stenosis: A Preliminary Analysis

S. Heffelfinger, P. Desai, J. Zhang, 2006, Blood Purification.

The 12th International Conference on Continuous Renal Replacement Therapies (CRRT). March 7–10, 2007, San Diego, Calif.

S. Heffelfinger, P. Stenvinkel, Sawako Kato, 2007, Blood Purification.

Hemodialysis vascular access dysfunction from basic biology to clinical intervention.

A. Narayana, S. Heffelfinger, P. Desai, 2002, Advances in renal replacement therapy.